Preparation and Evaluation of a Novel Class of Amphiphilic Amines as Antitumor Agents and Nanocarriers for Bioactive Molecules

por Orienti, Isabella, Falconi, Mirella, Teti, Gabriella, Currier, Mark A., Wang, Jiang, Phelps, Mitch, Cripe, Timothy P.
Publicado 2016

Opportunities and challenges of combining adoptive cellular therapy with oncolytic virotherapy

por Mamola, Joseph A., Chen, Chun-Yu, Currier, Mark A., Cassady, Kevin, Lee, Dean A., Cripe, Timothy P.
Publicado 2023

VEGF Blockade Decreases Tumor Uptake of Systemic Oncolytic Herpes Virus but Enhances Therapeutic Efficacy When Given After Virotherapy

por Eshun, Francis K., Currier, Mark A., Gillespie, Rebecca A., Fitzpatrick, Jillian L., Baird, William H., Cripe, Timothy P.
Publicado 2010

Cancer Screening by Systemic Administration of a Gene Delivery Vector Encoding Tumor-Selective Secretable Biomarker Expression

por Browne, Andrew W., Leddon, Jennifer L., Currier, Mark A., Williams, Jon P., Frischer, Jason S., Collins, Margaret H., Ahn, Chong H., Cripe, Timothy P.
Publicado 2011

Myelolytic Treatments Enhance Oncolytic Herpes Virotherapy in Models of Ewing Sarcoma by Modulating the Immune Microenvironment

por Denton, Nicholas L., Chen, Chun-Yu, Hutzen, Brian, Currier, Mark A., Scott, Thomas, Nartker, Brooke, Leddon, Jennifer L., Wang, Pin-Yi, Srinivas, Rachelle, Cassady, Kevin A., Goins, William F., Cripe, Timothy P.
Publicado 2018

Expression of HSV-1 Receptors in EBV-Associated Lymphoproliferative Disease Determines Susceptibility to Oncolytic HSV

por Wang, Pin-Yi, Currier, Mark A, Hansford, Loen, Kaplan, David, Chiocca, E. Antonio, Uchida, Hiroaki, Goins, William F., Cohen, Justus B., Glorioso, Joseph C., van Kuppevelt, Toin H., Mo, Xiaokui, Cripe, Timothy P
Publicado 2012

First-in-Human Intravenous Seprehvir in Young Cancer Patients: A Phase 1 Clinical Trial

por Streby, Keri A., Currier, Mark A., Triplet, Melinda, Ott, Kristy, Dishman, Devon J., Vaughan, Michele R., Ranalli, Mark A., Setty, Bhuvana, Skeens, Micah A., Whiteside, Stacy, Yeager, Nicholas D., Haworth, Kellie B., Simpson, Kathleen, Conner, Joe, Cripe, Timothy P.
Publicado 2019

Aurora A kinase inhibition enhances oncolytic herpes virotherapy through cytotoxic synergy and innate cellular immune modulation

por Currier, Mark A., Sprague, Les, Rizvi, Tilat A., Nartker, Brooke, Chen, Chun-Yu, Wang, Pin-Yi, Hutzen, Brian J., Franczek, Meghan R., Patel, Ami V., Chaney, Katherine E., Streby, Keri A., Ecsedy, Jeffrey A., Conner, Joe, Ratner, Nancy, Cripe, Timothy P.
Publicado 2017

Endogenous retrovirus envelope as a tumor-associated immunotherapeutic target in murine osteosarcoma

por Wedekind, Mary Frances, Miller, Katherine E., Chen, Chun-Yu, Wang, Pin-Yi, Hutzen, Brian J., Currier, Mark A., Nartker, Brooke, Roberts, Ryan D., Boon, Louis, Conner, Joe, LaHaye, Stephanie, Kelly, Benjamin J., Gordon, David, White, Peter, Mardis, Elaine R., Cripe, Timothy P.
Publicado 2021

Leveraging gene therapy to achieve long-term continuous or controllable expression of biotherapeutics

por Cripe, Timothy P., Hutzen, Brian, Currier, Mark A., Chen, Chun-Yu, Glaspell, Andrea M., Sullivan, Grace C., Hurley, Julia M., Deighen, Mackenzie R., Venkataramany, Akila S., Mo, Xiaokui, Stanek, Joseph R., Miller, Anthony R., Wijeratne, Saranga, Magrini, Vincent, Mardis, Elaine R., Mendell, Jerry R., Chandler, Dawn S., Wang, Pin-Yi
Publicado 2022

Oncolytic HSV virotherapy in murine sarcomas differentially triggers an antitumor T-cell response in the absence of virus permissivity

por Leddon, Jennifer L, Chen, Chun-Yu, Currier, Mark A, Wang, Pin-Yi, Jung, Francesca A, Denton, Nicholas L, Cripe, Kevin M, Haworth, Kellie B, Arnold, Michael A, Gross, Amy C, Eubank, Timothy D, Goins, William F, Glorioso, Joseph C, Cohen, Justus B, Grandi, Paola, Hildeman, David A, Cripe, Timothy P
Publicado 2015